TG Therapeutics Q4 EPS $(0.71) Misses $(0.58) Estimate, Sales $38.00K Inline
TG Therapeutics Q4 EPS $(0.71) Misses $(0.58) Estimate, Sales $38.00K Inline
TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.58) by 22.41 percent. This is a 61.36 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $38.00 thousand which met the analyst consensus estimate. This is the same as the same period last year.
TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.58) by 22.41 percent. This is a 61.36 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $38.00 thousand which met the analyst consensus estimate. This is the same as the same period last year.
TG治疗公司(纳斯达克：TGTX)公布季度亏损(0.71美元)，低于分析师普遍预期的(0.58美元)22.41%。这比去年同期每股亏损0.44美元减少了61.36%。该公司公布的季度销售额为380万美元，符合分析师的普遍预期。这与去年同期持平。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧